PRAX
Praxis Precision Medicines I
NASDAQ · Biotechnology
$319.57
+13.95 (+4.56%)
Performance
1D
—
1W
+3.38%
1M
+15.90%
3M
+74.10%
6M
+551.52%
1Y
+276.63%
YTD
+11.58%
Open$310.84
Previous Close$305.62
Day High$321.57
Day Low$309.26
52W High$326.91
52W Low$26.70
Volume450.8K
Avg Volume568.6K
Market Cap8.76B
P/E Ratio—
EPS$-12.90
SectorBiotechnology
Volume Analysis
0.79x average volume
Technical Indicators
SMA 50
$275.37
Above
SMA 200
$122.15
Above
RSI (14)
51
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-93.9% upside
Current
$319.57
$319.57
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.09M | 1.51B | 1.36B |
| Net Income | -279,812,693 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -305,813,800 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |